Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Capital Expenditures: 2020-2025

Historic Capital Expenditures for Sotera Health (SHC) over the last 6 years, with Sep 2025 value amounting to $36.2 million.

  • Sotera Health's Capital Expenditures fell 0.60% to $36.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $153.2 million, marking a year-over-year decrease of 13.95%. This contributed to the annual value of $179.1 million for FY2024, which is 16.70% down from last year.
  • Per Sotera Health's latest filing, its Capital Expenditures stood at $36.2 million for Q3 2025, which was up 15.83% from $31.2 million recorded in Q2 2025.
  • In the past 5 years, Sotera Health's Capital Expenditures registered a high of $71.7 million during Q4 2022, and its lowest value of $16.1 million during Q3 2021.
  • Its 3-year average for Capital Expenditures is $43.8 million, with a median of $41.9 million in 2024.
  • As far as peak fluctuations go, Sotera Health's Capital Expenditures skyrocketed by 142.10% in 2022, and later slumped by 42.91% in 2025.
  • Quarterly analysis of 5 years shows Sotera Health's Capital Expenditures stood at $41.3 million in 2021, then soared by 73.85% to $71.7 million in 2022, then declined by 9.63% to $64.8 million in 2023, then grew by 1.61% to $65.9 million in 2024, then dropped by 0.60% to $36.2 million in 2025.
  • Its Capital Expenditures stands at $36.2 million for Q3 2025, versus $31.2 million for Q2 2025 and $19.9 million for Q1 2025.